Clinical trials
Phase 2 Hepatitis B, Chronic trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2022 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Qilu Pharmaceutical Co., Ltd. | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
| Ascentage Pharma Group Inc. | 1 |
| Fuqiang Yang | 1 |
| Green Cross Corporation | 1 |
| Guangzhou Yipinhong Pharmaceutical CO.,LTD | 1 |
| Henlix, Inc | 1 |
| ImmuneMed, Inc. | 1 |
| LG Life Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 17 |
| Hepatitis B | 3 |
| Acquired Immunodeficiency Syndrome | 1 |
| Heartburn | 1 |
| Hepatitis | 1 |
| Hepatitis C | 1 |
| Hepatitis C, Chronic | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.